Unique ID issued by UMIN | UMIN000047060 |
---|---|
Receipt number | R000053660 |
Scientific Title | Effects of a research food on total body water |
Date of disclosure of the study information | 2022/09/10 |
Last modified on | 2022/09/07 08:32:33 |
Effects of a research food on total body water
Effects of a research food on total body water
Effects of a research food on total body water
Effects of a research food on total body water
Japan |
N/A(healthy adults)
Not applicable |
Others
NO
This study aims to examine effects of a research food on total body water.
Efficacy
Total body water
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Single ingestion of the test food - single ingestion of the placebo food
Single ingestion of the placebo food - single ingestion of the test food
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Men and women aged 20 to 65 years at the time of obtaining consent.
2)BMI of 18.5 kg/m^2or more but less than 25.0 kg/m^2.
3)Those who have received sufficient explanation of the test, understand the contents, and can give written consent in person.
4) Those who have completed two doses of the new coronavirus vaccine.
1)Those who have current medical treatments, or who are planning some kind of treatment the test period.
2)Those who constantly use medicines that may affect test results.(diuretic, antidiuretic, etc.).Those who take health foods and supplements (oral rehydration solution, saw palmettoetc.) daily, and those who may take or take them during the test period.
3)Those who are scheduled to take medication or receive vaccinations between one week before the first test date and the second test date.
4)Those who may onset seasonal allergies such as hay fever and take medicines during test period.
5)Those who may change their lifestyle (night shift, long trip, etc.) during test period.
6)Heavy drinkers of alcohol.
7)Those who have a history or current history of serious diseases of the heart, liver, kidneys, digestive organs, etc.
8)Individuals with probable seasonal allergy, such as pollinosis, during the test period.
9) Those who are pregnant, lactating, or intend to become pregnant during the study period.
10)Those with allergies to medicines or food.
11)Those who are currently participating in a clinical trial of another drug or health food, and plan to participate in another clinical trial within 4 weeks of the end of the trial, or after consenting to participate in the trial.
12)Patients who are judged to be inappropriate for participation in the study by the principal investigator or sub-investigator.
32
1st name | Toshihiro |
Middle name | |
Last name | Kawama |
Morinaga & Co., Ltd.
Health Science and Research Center, R&D institute
230-8504
2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama
045-571-6140
t-kawama-jb@morinaga.co.jp
1st name | Makoto |
Middle name | |
Last name | Morinaga |
Morinaga & Co., Ltd.
Health Science and Research Center, R&D institute
230-8504
2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama, Kanagawa
045-571-6140
m-morinaga-bj@morinaga.co.jp
Morinaga & Co., Ltd.
Morinaga & Co., Ltd.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-5548
IRB@cpcc.co.jp
NO
2022 | Year | 09 | Month | 10 | Day |
Unpublished
Completed
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 03 | Month | 17 | Day |
2022 | Year | 03 | Month | 25 | Day |
2022 | Year | 03 | Month | 02 | Day |
2022 | Year | 09 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053660